Scientific article
English

ß-Lactam Monotherapy vs ß-Lactam-Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia: A Randomized Noninferiority Trial

Published inJAMA internal medicine, vol. 174, no. 12, p. 1894-1901
Publication date2014
Abstract

The clinical benefit of adding a macrolide to a ß-lactam for empirical treatment of moderately severe community-acquired pneumonia remains controversial.

Citation (ISO format)
GARIN, Nicolas et al. ß-Lactam Monotherapy vs ß-Lactam-Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia: A Randomized Noninferiority Trial. In: JAMA internal medicine, 2014, vol. 174, n° 12, p. 1894–1901. doi: 10.1001/jamainternmed.2014.4887
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN2168-6106
705views
0downloads

Technical informations

Creation15/11/2014 13:54:00
First validation15/11/2014 13:54:00
Update time08/10/2024 09:17:18
Status update08/10/2024 09:17:18
Last indexation30/10/2024 21:33:50
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack